摘要:
An apparatus and method for controlling an image recording device. The apparatus includes an acousto-optic deflector that deflects a beam of light so as to write a sub-scan comprising a predetermined number of picture elements. The image recording device is arranged to write a plurality of sub-scans side by side in a substantially contiguous manner. The apparatus also includes a component that commences sub-scans, a start of sub-scan detector that detects when the light beam is directed towards a start of sub-scan position, and an end of sub-scan detector that detects when the beam of light is directed towards an end of sub-scan position. A timing logic controller generates a start reference signal representing a desired position for the start of a sub-scan. A controller compares an output of the start of sub-scan detector with respect to the start reference signal. The controller also adjusts a frequency range of a chirp applied to the acousto-optic deflector while keeping a start time of the chirp constant so as to cause an arrival time of the light beam at the start of sub-scan detector to coincide with the start reference signal. A picture element rate controller adjusts a rate at which picture elements are written such that a final one of the picture elements is written a predetermined period before the light beam is directed towards the end of sub-scan position.
摘要:
A rotary drum scanner comprises a rotatably mounted hub, a drum detachably mounted to the hub and an interlock mechanism which locks the hub against rotation until the drum is locked to the hub.
摘要:
3-Carbamoyloxymethyl and 3-N-methylcarbamoyloxymethyl cephalosporin antibiotics in which the 7.beta.-acylamido group has the structure ##STR1## where R is thienyl, furyl or phenyl; R.sup.a is C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.3-7 cycloalkyl or phenyl, and R.sup.b is hydrogen, carboxy, C.sub.2 -C.sub.5 carbalkoxy or any of the groups designated for R.sup.a, or R.sup.a and R.sup.b together with the carbon atom to which they are attached form a C.sub.3-7 cycloalkylidene or cycloalkenylidene group; exhibit broad spectrum antibiotic activity charcterized by particularly high activity against gram negative microorganisms, including those which produce .beta.-lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly high in vitro activity against strains of Escherichia coli, Haemophilus influenzae and Proteus organisms; and also shown unusually high activity against Pseudomonas organisms.
摘要:
The invention provides novel antibiotic compounds which are 7.beta.-acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof characterized in that the acylamido group has the structure ##STR1## WHERE R is a hydrogen atom or an organic group and R.sup.a is an etherifying monovalent organic group linked to the oxygen atom through a carbon atom. The compounds are syn isomers or exist as mixtures containing at least 75% of the syn isomer. These antibiotic compounds possess high antibacterial activity against a range of gram positive and gram negative organisms coupled with particularly high stability to .beta.-lactamases produced by various gram negative organisms. The invention is also concerned with the administration of the compounds.
摘要:
The invention provides novel antibiotic compounds which are 7.beta.-acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof characterized in that the acylamido group has the structure ##EQU1## where R is a hydrogen atom or an organic group and R.sup.a is an etherifying monovalent organic group linked to the oxygen atom through a carbon atom. The compounds are syn isomers or exist as mixtures containing at least 75% of the syn isomer. These antibiotic compounds possess high antibacterial activity against a range or gram positive and gram negative organisms coupled with particularly high stability to .beta.-lactamases produced by various gram negative organisms. The invention is also concerned with the administration of the compounds.
摘要翻译:本发明提供了新的抗生素化合物,它们是7β-酰基酰胺基头孢-3-烯-4-羧酸,以及其无毒的衍生物,其特征在于酰基酰氨基具有结构式RCCO NH-平衡N | a OR,其中R是 氢原子或有机基团,Ra是通过碳原子与氧原子连接的醚化一价有机基团。 这些化合物是顺式异构体,或作为含有至少75%的顺式异构体的混合物存在。 这些抗生素化合物对一系列或革兰氏阳性和革兰氏阴性生物具有高抗菌活性,与各种革兰氏阴性生物体产生的β-内酰胺酶具有特别高的稳定性。 本发明还涉及化合物的给药。
摘要:
Processing within an emulated computing environment is facilitated. Code used to implement system-provided (e.g., standard or frequently used) routines referenced in an application being emulated is native code available for the computing environment, rather than emulated code. Responsive to encountering a reference to a system-provided routine in the application being emulated, the processor is directed to native code, rather than emulated code, even though the application is being emulated.
摘要:
An axial flow rotary blood pump including an impeller adapted to be magnetically rotated within a housing by the interaction of magnets disposed on or in the impeller and stators disposed on or in the housing. The impeller includes at least one support ring supporting a plurality of blades, and a hydrodynamic bearing that operates at least axially and radially in respect of an axis of rotation of the impeller.
摘要:
An axial flow rotary blood pump including an impeller (5) adapted to be magnetically rotated within a housing by the interaction of magnets disposed on or in the impeller and stators disposed on or in the housing. The impeller includes at least one support ring (2) supporting a plurality of blades (4), and a hydrodynamic bearing (3) that operates at least axially and radially in respect of an axis of rotation of the impeller (5).